Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2025

SELL
$31.15 - $33.39 $154,099 - $165,180
-4,947 Reduced 23.07%
16,493 $547,000
Q4 2022

Feb 14, 2023

SELL
$31.15 - $33.39 $154,099 - $165,180
-4,947 Reduced 23.07%
16,493 $547,000
Q3 2022

Feb 07, 2025

BUY
$30.9 - $33.55 $662,496 - $719,311
21,440 New
21,440 $676,000
Q3 2022

Mar 03, 2023

BUY
$30.9 - $33.55 $152,862 - $165,971
4,947 Added 29.99%
21,440 $676,000
Q3 2022

Nov 14, 2022

SELL
$30.9 - $33.55 $8,157 - $8,857
-264 Reduced 1.22%
21,440 $676,000
Q2 2022

Aug 15, 2022

SELL
$23.75 - $31.69 $6,840 - $9,126
-288 Reduced 1.31%
21,704 $660,000
Q1 2022

May 16, 2022

BUY
$19.97 - $26.94 $104,063 - $140,384
5,211 Added 31.05%
21,992 $571,000
Q4 2021

Feb 14, 2022

SELL
$17.46 - $21.61 $373,870 - $462,734
-21,413 Reduced 56.06%
16,781 $342,000
Q3 2021

Nov 15, 2021

BUY
$17.35 - $22.5 $1,283 - $1,665
74 Added 0.19%
38,194 $735,000
Q2 2021

Aug 16, 2021

SELL
$18.01 - $28.32 $31,985 - $50,296
-1,776 Reduced 4.45%
38,120 $846,000
Q1 2021

May 17, 2021

BUY
$19.76 - $29.89 $62,125 - $93,974
3,144 Added 8.55%
39,896 $1.05 Million
Q4 2020

Feb 16, 2021

BUY
$15.73 - $21.66 $63,077 - $86,856
4,010 Added 12.25%
36,752 $687,000
Q3 2020

Nov 16, 2020

SELL
$13.54 - $26.41 $5,023 - $9,798
-371 Reduced 1.12%
32,742 $556,000
Q2 2020

Aug 14, 2020

SELL
$7.84 - $23.29 $194,188 - $576,870
-24,769 Reduced 42.79%
33,113 $771,000
Q1 2020

May 15, 2020

SELL
$5.57 - $11.5 $5,224 - $10,787
-938 Reduced 1.59%
57,882 $486,000
Q4 2019

Feb 14, 2020

BUY
$7.9 - $10.14 $127,719 - $163,933
16,167 Added 37.9%
58,820 $575,000
Q3 2019

Nov 14, 2019

SELL
$9.17 - $12.01 $1,870 - $2,450
-204 Reduced 0.48%
42,653 $405,000
Q2 2019

Aug 14, 2019

BUY
$10.88 - $17.6 $274,883 - $444,664
25,265 Added 143.62%
42,857 $509,000
Q1 2019

May 15, 2019

SELL
$15.51 - $17.61 $25,343 - $28,774
-1,634 Reduced 8.5%
17,592 $310,000
Q4 2018

Feb 14, 2019

BUY
$14.52 - $19.72 $10,919 - $14,829
752 Added 4.07%
19,226 $334,000
Q2 2018

Aug 14, 2018

SELL
$13.8 - $16.8 $21,541 - $26,224
-1,561 Reduced 7.79%
18,474 $294,000
Q1 2018

May 15, 2018

SELL
$13.8 - $16.2 $29,683 - $34,846
-2,151 Reduced 9.7%
20,035 $284,000
Q3 2017

Nov 14, 2017

BUY
$13.45 - $14.35 $298,401 - $318,369
22,186
22,186 $317,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.